journal article·2026-06Open access

Chiral of D-type mesoporous silica deliver anti-inflammatory drug with double synergism

Xue Yan, Lu Wang, Zhixiao Zhang, Xianbao Shi, Guowei Li

Abstract

Chiral drug delivery systems have gained great attention in novel drug delivery applications. To explore their exceptional functions, a series of chiral mesoporous silica xerogel (L-SX, D-SX) was constructed using biomimetic method and another series of chiral mesoporous silica nanoparticles (L-MSNs, D-MSNs) were established by applying chiral grafting method. Poorly water-soluble celecoxib (CXB) was chosen to load into these chiral carriers as well as corresponding control carrier, and further to study characteristics and delivery effects of drug loaded carriers. The results indicated that all these chiral carriers formed hydrogen bonds with drugs and can successfully convert drug crystal phase to amorphous state so as to enhance drug dissolution compared to raw drug. In vivo pharmacokinetics and pharmacodynamics results demonstrated that D-SX and D-MSNs turned out to be the best CXB carriers possibly owing to their chiral grafted groups and therefore obtaining double synergism of drug delivery enhancement and superior anti-inflammation effect, which can significantly revolutionize anti-inflammatory drug treatment. • Chiral mesoporous silica xerogel was originally established using chiral threonine • Chiral mesoporous silica nanoparticles were firstly formed by chiral tartaric acid • D-type mesoporous silica delivered celecoxib with superior anti-inflammatory effect • D-type mesoporous silica achieved higher drug bioavailability than some reports
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Mesoporous Materials and Catalysis · Aerogels and thermal insulation · Analytical Chemistry and Chromatography

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (42)

Show source-provided references
1. Chiral metal–organic frameworks based on asymmetric synthetic strategies and applications
2. Chiral porous organic frameworks and their application in enantioseparation
3. Enantiomer-dependent immunological response to chiral nanoparticles10.1038/s41586-021-04243-2 ↗
4. Recent advances in inorganic chiral nanomaterials
5. Superiority of Chiral-handed mesoporous silica nanoparticles in delivering nimesulide
6. Regional intestinal drug absorption: biopharmaceutics and drug formulation10.3390/pharmaceutics13020272 ↗
7. Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences10.1016/j.cis.2020.102261 ↗
8. Labrasol-enriched nanoliposomal formulation: novel approach to improve oral absorption of water-insoluble drug10.1208/s12249-018-1118-9 ↗
9. Application of lipid blend-based nanoparticulate scaffold for oral delivery of antihypertensive drug: implication on process variables and in vivo absorption assessment10.1007/s12247-018-9329-x ↗
10. Combination of phospholipid complex and submicron emulsion techniques for improving oral bioavailability and therapeutic efficacy of water-insoluble drug10.1021/acs.molpharmaceut.7b01061 ↗
11. Nanocrystal solid dispersion of fuzapladib free acid with improved oral bioavailability10.1002/bdd.2314 ↗
12. Functionalized mesoporous silica nanoparticles in anticancer therapeutics10.1016/j.semcancer.2019.08.022 ↗
13. Antimicrobial nanoparticles and biodegradable polymer composites for active food packaging applications10.1111/1541-4337.12727 ↗
14. A highly ordered chiral inorganic mesoporous material used as stationary phase for high-resolution gas chromatographic separations10.1016/j.chroma.2018.05.005 ↗
15. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment10.1016/j.msec.2020.111526 ↗
16. Bioinspired diselenide‐bridged mesoporous silica nanoparticles for dual‐responsive protein delivery
17. Enzyme-functionalized mesoporous silica nanoparticles to target Staphylococcus aureus and disperse biofilms10.2147/IJN.S293190 ↗
18. Metformin-induced stromal depletion to enhance the penetration of gemcitabine-loaded magnetic nanoparticles for pancreatic cancer targeted therapy10.1021/jacs.0c00650 ↗
19. Biomimetic silica xerogel regulates indometacin release and oral bioavailability by virtue of chiral pores10.1016/j.micromeso.2019.109834 ↗
20. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine10.1039/D0CS01127D ↗
21. Magnetic mesoporous silica nanoparticles cloaked by red blood cell membranes: applications in cancer therapy10.1002/anie.201712996 ↗
22. Large‐pore mesoporous‐silica‐coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy10.1002/adma.201802479 ↗
23. Small molecules modified mesoporous silica nanoparticles orally deliver indomethacin with synergistic effect10.1016/j.ejps.2024.106719 ↗
24. Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances10.3390/pharmaceutics10030118 ↗
25. Tumor microenvironment‐responsive mesoporous MnO2‐coated upconversion nanoplatform for self‐enhanced tumor theranostics10.1002/adfm.201803804 ↗
26. Pectinase-responsive carriers based on mesoporous silica nanoparticles for improving the translocation and fungicidal activity of prochloraz in rice plants10.1016/j.cej.2020.126440 ↗
27. Trypsin templated biomimetic large mesoporous silica performs favorable advantages in delivering poorly water-soluble drug10.1016/j.mseb.2021.115252 ↗
28. Exploring mesoporous silica microparticles in pharmaceutical sciences: drug delivery and therapeutic insights
29. An insight on Pillararene-Functionalized mesoporous silica nanoparticles for targeted drug delivery and theranostics in cancer10.1021/acs.molpharmaceut.5c00729 ↗
30. Mesoporous systems for poorly soluble drugs-recent trends10.1016/j.ijpharm.2017.11.054 ↗
31. Approaching drug release performance from mesoporous silica formulations by modeling of chemical potentials10.1016/j.ejps.2025.107283 ↗
32. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system
33. Superiority of L-tartaric acid modified chiral mesoporous silica nanoparticle as a drug carrier: structure, wettability, degradation, bio-adhesion and biocompatibility10.2147/IJN.S233740 ↗
34. Biomimetic synthesized nanoporous silica@poly(ethyleneimine)s xerogel as drug carrier: characteristics and controlled release effect10.1016/j.ijpharm.2014.03.045 ↗
35. How biomimetic amino modified mesoporous silica xerogel regulates loading and in vitro sustained delivery of levorotary ofloxacin10.1016/j.msec.2019.110266 ↗
36. Mutual interaction between guest drug molecules and host nanoporous silica xerogel studied using central composite design10.1016/j.ijpharm.2015.12.005 ↗
37. Intestinal absorption of phenolic acids in Rhus chinensis extracts by in situ single-pass perfusion model in rats
38. Hydroxypropyl methylcellulose E5 with molecular energy-enhancement ability contributes to improving wettability, drug delivery and taste masking effect for curcumin solid dispersions10.1016/j.ijbiomac.2025.140715 ↗
39. Effect of shape on mesoporous silica nanoparticles for oral delivery of indomethacin10.3390/pharmaceutics11010004 ↗
40. Double-nano silica xerogel contributes to establish nifedipine delivery system with superior delivery effect10.1016/j.micromeso.2019.109996 ↗
41. Concealed body mesoporous silica nanoparticles for orally delivering indometacin with chiral recognition function10.1016/j.msec.2018.04.071 ↗
42. Bioavailability of celecoxib formulated with mesoporous magnesium Carbonate-An In vivo evaluation10.3390/molecules27196188 ↗